Seeking Alpha

Michael Sweeney's  Instablog

Michael Sweeney
Send Message
Michael Sweeney is the Bitcoin Partner of Film Annex Networks the venture division of Film Annex, which has been ranked as one of the Top 100 web sites in America with over 25+ million unique visitors per month. Film Annex's business model includes: * Paying content providers through the Film... More
My company:
Film Annex Networks
My blog:
Film Annex Networks Blog
  • Stop Smoking article at New York Times - 22nd Century's ($XXII) featured  0 comments
    Nov 3, 2011 4:13 PM

    22nd Century Ltd, LLC (OTCBB: XXII; Twitter: $XXII) is a plant biotechnology company whose proprietary technology allows for the level of nicotine (and other nicotinic alkaloids) in the tobacco plant to be decreased or increased through genetic engineering and breeding. XXII was featured in an article at the NY Times titled:

    "Cigarettes Are Enlisted to Test Ways of Quitting"

    The NY Times stated:

    "Researchers had been seeking a new and bigger supply because shortages had limited previous studies to just dozens of people. The experimental cigarettes are produced by the 22nd Century Group, which holds 98 patents for genetic manipulation of tobacco plants to reduce or increase the amount of nicotine in cigarettes.

    The National Institutes of Health bought nine million of these cigarettes, marked “for research purposes only,” from the 22nd Century Group as part of a broadening scientific effort to find ways to regulate cigarettes so that they are nonaddictive. The Spectrum brand test cigarettes have eight different levels of nicotine for research, from a nicotine content of 3 percent to 100 percent of the nicotine in the best-selling Marlboro Gold, though a 97 percent reduction is the most common level."

    Preliminary studies show smokers can have an easier time quitting if they taper off the nicotine  while still being able to do all the other things they do with cigarettes, but larger studies are needed. Joseph Pandolfino, the Founder and CEO of 22nd Century, was quoted in the article:

    “No one has ever sought F.D.A. approval of a cigarette as a medical device.” 

    See the full article @ The New York Times.

Back To Michael Sweeney's Instablog HomePage »

Instablogs are blogs which are instantly set up and networked within the Seeking Alpha community. Instablog posts are not selected, edited or screened by Seeking Alpha editors, in contrast to contributors' articles.

Comments (0)
Track new comments
Be the first to comment
Full index of posts »
Latest Followers

StockTalks

More »
Posts by Themes
Instablogs are Seeking Alpha's free blogging platform customized for finance, with instant set up and exposure to millions of readers interested in the financial markets. Publish your own instablog in minutes.